{"protocolSection":{"identificationModule":{"nctId":"NCT03422900","orgStudyIdInfo":{"id":"CASVE-NM-17-315"},"organization":{"fullName":"Endocrinology and Clinical Nutrition Research Center, Spain","class":"OTHER"},"briefTitle":"Hyperglycemia in Patients With Stroke and Indication of Enteral Nutrition","officialTitle":"Influence of Two Enteral Nutrition Formulas on Hyperglycemia and Morbidity in Patients With Stroke","acronym":"GlyENStroke"},"statusModule":{"statusVerifiedDate":"2018-01","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-12-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-06-15","type":"ESTIMATED"},"completionDateStruct":{"date":"2020-12-15","type":"ESTIMATED"},"studyFirstSubmitDate":"2017-12-10","studyFirstSubmitQcDate":"2018-01-30","studyFirstPostDateStruct":{"date":"2018-02-06","type":"ACTUAL"},"lastUpdateSubmitDate":"2018-01-30","lastUpdatePostDateStruct":{"date":"2018-02-06","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Daniel de Luis Roman","investigatorTitle":"Profesor Doctor","investigatorAffiliation":"Endocrinology and Clinical Nutrition Research Center, Spain"},"leadSponsor":{"name":"Endocrinology and Clinical Nutrition Research Center, Spain","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate the effect of a specific nutritional formula for diabetics on the development of hyperglycemia in patients with recent non-diabetic stroke who require admission and enteral nutritional support by nasogastric tube. As well as the effect on metabolic control, development of comorbidities, hospital stay, readmissions, mortality and tolerance of the formula under study.","detailedDescription":"MAIN GOAL:\n\nTo evaluate the effect on the development of hyperglycemia diagnosed as glycemia\\> 126 mg / dl on an empty stomach or\\> 150 mg / dl during the infusion of enteral nutrition determined by capillary glycemia during the admission of a specific formula in patients with a first episode of ischemic stroke or hemorrhagic entry into the non-diabetic HCUV stroke unit requiring enteral nutrition by nasogastric tube."},"conditionsModule":{"conditions":["Hyperglycaemia (Non Diabetic)","Enteral Feeding Intolerance","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Comparison of two formulas of enteral nutrition (diabetes-specific enteral formula (lower glycemic index and presence of soluble and insoluble fiber) compared to an standard formula (isocaloric and isonitrogenated formula without fiber)) in patients without diabetes mellitus admitted due to stroke and with indication of nutritional support by nasogastric tube","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","maskingDescription":"cover label","whoMasked":["PARTICIPANT","CARE_PROVIDER"]}},"enrollmentInfo":{"count":150,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Specific Diabetes Formula","type":"EXPERIMENTAL","description":"Diabetes-Specific Enteral Formula:\n\n* Caloric density: 1,0 kcal/ml\n* Energy: 100 kcal\n* Carbohydrates: 10,1 g/100 ml;\n* Fat: 4,5 g/100 ml\n* Prot: 3,8 g/100 ml\n* Osmolarity: 345 mOsm/l\n* Fiber: 1,78 g/100 ml (80% soluble; 20% insoluble).","interventionNames":["Dietary Supplement: Diabetes-Specific enteral formula"]},{"label":"Standard Formula","type":"ACTIVE_COMPARATOR","description":"Standard Enteral Formula:\n\n* Caloric density: 1,0 kcal/ml\n* Energy: 100 kcal\n* Carbohydrates: 13,8 g/100 ml;\n* Fat: 3,4 g/100 ml\n* Prot: 3,8 g/100 ml\n* Osmolarity: 220 mOsm/l\n* Fiber: 0 g/100 ml","interventionNames":["Dietary Supplement: Standard formula"]}],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Diabetes-Specific enteral formula","description":"Complete enteral formula normocaloric hyperproteic with fiber (80% SOLUBLE)","armGroupLabels":["Specific Diabetes Formula"],"otherNames":["DIABA"]},{"type":"DIETARY_SUPPLEMENT","name":"Standard formula","description":"Complete enteral formula normocaloric hormoproteic without fiber","armGroupLabels":["Standard Formula"],"otherNames":["Fresubin Original"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"HYPERGLUCEMIA POST-ENTERAL NUTRITION","description":"Glycemia over 150 mg / dl after the beginning of infusion of complete enteral. nutrition determined by capillary glycemia during admission. Dicotomic variable (Yes/No)","timeFrame":"2 WEEKS"}],"secondaryOutcomes":[{"measure":"MORTALITY","description":"Mortality during study period. Dicotomic variable (Yes/No)","timeFrame":"3 months"},{"measure":"ORAL FEEDING RECOVERY","description":"Recovery of oral feeding (More than 75% of energy needs) and withdrawal of nasogastric tube during admission. Dicotomic variable (Yes/No)","timeFrame":"3 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Admitted for a first episode of ischemic or hemorrhagic stroke.\n* Requiring total enteral nutrition by tube for at least 7 days\n\nExclusion Criteria:\n\n* Contraindication to enteral nutrition\n* Diabetes Mellitus\n* Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting, abdominal pain\n* Need for admission to the ICU\n* Previous neurodegenerative disease\n* Antibiotherapy for 7 days prior to the inclusion visit\n* Allergies or intolerances to any of the components of the formula under study\n* Pregnant patients","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Juan J López-Gómez, Prof. Dr.","role":"CONTACT","phone":"983420000","phoneExt":"86158","email":"jjlopez161282@hotmail.com"},{"name":"Daniel A De Luis-Román, Prof. Dr.","role":"CONTACT","phone":"983420000","phoneExt":"86660","email":"dadluis@yahoo.es"}],"overallOfficials":[{"name":"Daniel A De Luis Román, Prof. Dr.","affiliation":"Service of Endocrinology and Nutrition. Clinic Hospital University of Valladolid","role":"STUDY_DIRECTOR"},{"name":"Juan J López-Gómez, Prof. Dr.","affiliation":"Service of Endocrinology and Nutrition. Clinic Hospital University of Valladolid","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Javier F Arenillas-Lara, Prof. Dr.","affiliation":"Service of Neurology. Clinic Hospital University of Valladolid","role":"STUDY_CHAIR"}],"locations":[{"facility":"Clinic Universitary Hospital","status":"RECRUITING","city":"Valladolid","zip":"47003","country":"Spain","contacts":[{"name":"Juan J López-Gómez, Prof. Dr.","role":"CONTACT","phone":"983420000","phoneExt":"86158","email":"jjlopez161282@hotmail.com"},{"name":"Daniel A De Luis-Román, Prof. Dr.","role":"CONTACT","phone":"983420000","phoneExt":"86660","email":"dadluis@yahoo.es"},{"name":"Daniel A De Luis-Román, Prof. Dr.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Juan J López-Gómez, Prof. Dr.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Javier F Arenillas-Lara, Prof. Dr.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Esther Delgado-García, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Emilia Gómez-Hoyos, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Ana Ortolá-Buigues, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Beatriz Torres-Torres, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Ana Calleja-Sanz, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Elisa Cortijo-García, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Mercedes De Lera, Dra.","role":"SUB_INVESTIGATOR"},{"name":"Ángeles Castro-Lozano, Dipl.","role":"SUB_INVESTIGATOR"},{"name":"Silvia Rodríguez-Gómez, Dipl.","role":"SUB_INVESTIGATOR"},{"name":"Lourdes De Marcos-White, Dipl.","role":"SUB_INVESTIGATOR"},{"name":"Beatriz Gómez-Vicente, Dipl.","role":"SUB_INVESTIGATOR"},{"name":"Pedro L Muñoz-Rubio, Dipl","role":"SUB_INVESTIGATOR"},{"name":"Javier Reyes-Muñoz, Dipl","role":"SUB_INVESTIGATOR"},{"name":"Rosa Alcaide-Flores, Dipl","role":"SUB_INVESTIGATOR"},{"name":"Ana Martín, Dipl","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":41.65518,"lon":-4.72372}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000006943","term":"Hyperglycemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000044882","term":"Glucose Metabolism Disorders"},{"id":"D000008659","term":"Metabolic Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M9684","name":"Hyperglycemia","asFound":"Hyperglycemia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M11329","name":"Metabolic Diseases","relevance":"LOW"},{"id":"M25093","name":"Glucose Metabolism Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"}]}},"hasResults":false}